Clinical Trials Directory

Trials / Completed

CompletedNCT00640341

Comparative Performance of PureVision, Acuvue Oasys and O2Optix

Product Performance of Bausch & Lomb PureVision® Contact Lens When Compared to Johnson & Johnson Acuvue Oasys Contact Lens and the Ciba Vision O2Optix Contact Lens Worn Daily.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
510 (actual)
Sponsor
Bausch & Lomb Incorporated · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to evaluate the performance of the PureVision Contact Lens compared to Acuvue Oasys Contact lens and O2Optix Contact lens when worn on a daily wear basis.

Conditions

Interventions

TypeNameDescription
DEVICEPureVision Contact Lenscontact lens for daily wear
DEVICEAcuvue Oasys Contact Lenscontact lens for daily wear
DEVICEO2Optix Contact lenscontact lens for daily wear

Timeline

Start date
2008-02-01
Primary completion
2008-04-01
Completion
2008-04-01
First posted
2008-03-21
Last updated
2011-12-12
Results posted
2011-03-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00640341. Inclusion in this directory is not an endorsement.

Comparative Performance of PureVision, Acuvue Oasys and O2Optix (NCT00640341) · Clinical Trials Directory